269 related articles for article (PubMed ID: 20482269)
1. In vitro susceptibility to various antibiotics of colistin-resistant gram-negative bacterial isolates in a general tertiary hospital in Crete, Greece.
Samonis G; Matthaiou DK; Kofteridis D; Maraki S; Falagas ME
Clin Infect Dis; 2010 Jun; 50(12):1689-91. PubMed ID: 20482269
[No Abstract] [Full Text] [Related]
2. Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study.
Matthaiou DK; Michalopoulos A; Rafailidis PI; Karageorgopoulos DE; Papaioannou V; Ntani G; Samonis G; Falagas ME
Crit Care Med; 2008 Mar; 36(3):807-11. PubMed ID: 18431267
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria.
Li J; Nation RL; Milne RW; Turnidge JD; Coulthard K
Int J Antimicrob Agents; 2005 Jan; 25(1):11-25. PubMed ID: 15620821
[TBL] [Abstract][Full Text] [Related]
4. The comparison of susceptibility patterns of Gram-negative invasive and non-invasive pathogens in Estonian hospitals.
Lõivukene K; Kermes K; Sepp E; Adamson V; Mitt P; Jürna M; Mägi H; Kallandi U; Otter K; Naaber P
Antonie Van Leeuwenhoek; 2006; 89(3-4):367-71. PubMed ID: 16779633
[TBL] [Abstract][Full Text] [Related]
5. Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients.
Falagas ME; Rafailidis PI; Matthaiou DK; Virtzili S; Nikita D; Michalopoulos A
Int J Antimicrob Agents; 2008 Nov; 32(5):450-4. PubMed ID: 18768302
[TBL] [Abstract][Full Text] [Related]
6. Mutant prevention concentrations of colistin for Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae clinical isolates.
Choi MJ; Ko KS
J Antimicrob Chemother; 2014 Jan; 69(1):275-7. PubMed ID: 23997018
[No Abstract] [Full Text] [Related]
7. Mutant prevention concentrations of colistin used in combination with other antimicrobial agents against Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa clinical isolates.
Choi MJ; Park YK; Peck KR; Ko KS
Int J Antimicrob Agents; 2014 Nov; 44(5):475-6. PubMed ID: 25443890
[No Abstract] [Full Text] [Related]
8. Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?
Falagas ME; Bliziotis IA
Int J Antimicrob Agents; 2007 Jun; 29(6):630-6. PubMed ID: 17306965
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V
Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
[TBL] [Abstract][Full Text] [Related]
10. Comparison of E-test and disc diffusion methods for the in vitro evaluation of the antimicrobial activity of colistin in multi-drug resistant Gram-negative Bacilli.
Somily AM
Saudi Med J; 2010 May; 31(5):507-11. PubMed ID: 20464039
[TBL] [Abstract][Full Text] [Related]
11. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
13. Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals.
Falagas ME; Skalidis T; Vardakas KZ; Legakis NJ;
J Antimicrob Chemother; 2017 Jun; 72(6):1704-1708. PubMed ID: 28369471
[TBL] [Abstract][Full Text] [Related]
14. In-vitro bactericidal activity of colistin against biofilm-associated Pseudomonas aeruginosa and Acinetobacter baumannii.
Cai Y; Wang R; Liang BB; An MM
J Hosp Infect; 2009 Aug; 72(4):368-70. PubMed ID: 19443079
[No Abstract] [Full Text] [Related]
15. The in-vitro activity of colistin in gram-negative bacteria.
Tan TY; Ng SY
Singapore Med J; 2006 Jul; 47(7):621-4. PubMed ID: 16810437
[TBL] [Abstract][Full Text] [Related]
16. Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY.
Landman D; Bratu S; Kochar S; Panwar M; Trehan M; Doymaz M; Quale J
J Antimicrob Chemother; 2007 Jul; 60(1):78-82. PubMed ID: 17490999
[TBL] [Abstract][Full Text] [Related]
17. Surveillance of antimicrobial susceptibility among bacterial isolates from intensive care unit patients of a tertiary-care university hospital in Iran: 2006-2009.
Mohammadtaheri Z; Pourpaki M; Mohammadi F; Namdar R; Masjedi MR
Chemotherapy; 2010; 56(6):478-84. PubMed ID: 21099220
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolates.
Landman D; Singh M; El-Imad B; Miller E; Win T; Quale J
Int J Antimicrob Agents; 2014 Jun; 43(6):527-32. PubMed ID: 24796217
[TBL] [Abstract][Full Text] [Related]
19. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
Xiao QZ; Su DH; Jiang JH; Zhong NS
Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):132-8. PubMed ID: 15698988
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of Colistin-Resistant, Gram-Negative Bacteria to Antimicrobial Peptides and Ceragenins.
Hashemi MM; Rovig J; Weber S; Hilton B; Forouzan MM; Savage PB
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]